Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Growth hormone-releasing hormone (GHRH), a hypothalamic polypeptide, acts as a potent autocrine/paracrine growth factor in many cancers. Benign prostatic hyperplasia (BPH) is a pathologic proliferation of prostatic glandular and stromal tissues; a variety of growth factors and inflammatory processes...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rick, Ferenc G., Schally, Andrew V., Block, Norman L., Nadji, Mehrdad, Szepeshazi, Karoly, Zarandi, Marta, Vidaurre, Irving, Perez, Roberto, Halmos, Gabor, Szalontay, Luca
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2011
Konular:
Biological Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3048153/
https://ncbi.nlm.nih.gov/pubmed/21321192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1018086108
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller